首页> 外文期刊>Asian Journal of Urology >Effect of puboprostatic ligament preservation during robotic-assisted laparoscopic radical prostatectomy on early continence: Randomized controlled trial
【24h】

Effect of puboprostatic ligament preservation during robotic-assisted laparoscopic radical prostatectomy on early continence: Randomized controlled trial

机译:植物辅助腹腔镜自由基前列腺切除术治疗潘文术韧带保存的影响:随机对照试验

获取原文
       

摘要

ObjectiveTo prove the effectiveness of puboprostatic ligament-preserving robotic-assisted laparoscopic radical (RARP) on enhancing early continence.MethodsNinety-two patients with localized adenocarcinoma of the prostate scheduled for RARP from April 2018 to January 2019 were prospectively single-blinded and randomized into two groups, standard RARP (Group A) and puboprostatic ligament-sparing RARP (Group B). The outcomes were continent status at Foley catheter removal and 3 months after surgery using the score from the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF), pad usage, pathological margin status, blood loss, operative time, and complications.ResultsNinety-six patients were randomized (46 patients in each group), with a mean±SD age of 67.30±6.07 years. There were no differences in baseline characteristics. At 3 months after surgery, ICIQ-UI SF score (mean±SD) in Group A was significantly higher than Group B (8.74±4.28vs.6.93±3.96,p=0.038) but no difference at Foley catheter removal. Group A also had a significant higher score for interference with daily life (median [interquartile range, IQR]: 4 [1, 5]vs.2 [0, 4];p=0.041) and higher pad use (median [IQR]: 2 [0, 3]vs.1 [1, 2];p=0.041) at 3 months. One case in Group A had complete or severe incontinence (>5 pads/day) at 3 months. Groups A and B did not exhibit significant difference in margin status (p=0.828). There were no differences in operative time, blood loss, drain output or complications.ConclusionsUse of puboprostatic ligament-sparing RARP could be a method to accelerate early continence without affecting the final oncological outcome.
机译:atfectoriveto证明了潘普鲁科韧带保存的机器人辅助腹腔镜自由基(RARP)对增强的持续增强的有效性。从2018年4月至2019年4月到2019年1月的RARP局部腺癌的一定患者预计单一盲目并随机分为两种组,标准RARP(A组)和PubProstatic韧带 - 备用RARP(B组)。结果是在Foley导管去除和手术后3个月的营销的大陆地位,使用国际咨询问卷调查问卷 - 尿失禁短型(ICIQ-UI SF),PAD使用,病理保证金状态,血液损失,手术时间和并发症。培养六患者是随机的(每组46名患者),平均±SD级为67.30±6.07岁。基线特征没有差异。在手术后3个月,A组ICIQ-UI SF得分(平均值±SD)明显高于B组(8.74±4.28Vs.6.93±3.96,P = 0.038),但在Foley导管移除没有差异。 A组也具有显着更高的干扰与日常生活的分数(中位数[四分位数,IQR]:4 [1,5] Vs.2 [0,4]; P = 0.041)和更高的垫使用(中位数[IQR] :3个月,2 [0,3] Vs.1 [1,2]; p = 0.041)。 A组中的一种案例在3个月内完成了完全或严重的尿失禁(> 5垫/日)。 A和B组没有表现出显着的边际状态差异(p = 0.828)。操作时间没有差异,失血,排水输出或并发症。泛扰动韧带抑制RARP的结合可能是加速早期持续的方法而不影响最终的肿瘤政治结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号